About our Editors

New Content ItemRaymond Birge, Editor-in-Chief
Rutgers, The State University of New Jersey, USA

Raymond Birge, PhD., is a Professor at Rutgers, The State University of New Jersey and a member of the New Jersey Medical School Cancer Center. Dr. Birge received a B.S. from the University of Connecticut (1984), and a PhD. in Biochemical Toxicology (1989), also from the University of Connecticut. He completed postdoctoral training at the Rockefeller University in New York with Professor Hidesaburo Hanafusa from 1989 to 1984 and was Assistant Professor of the Laboratory of Molecular Oncology at Rockefeller University from 1994 to 2000. Dr. Birge joined UMDNJ-New Jersey Medical School in 2000 and currently holds a position of Professor and Vice Chair for Research in the Department of Microbiology, Biochemistry and Molecular Biology. Dr. Birge also has joint appointments at the New Jersey Medical School Cancer Center (Newark) and the Cancer Institute of New Jersey (New Brunswick).

Dr. Birge's research focuses on apoptosis and cancer biology, emphasizing genes and signaling pathways that promote tumor progression, metastatis, and immune escape. He was the founding member (with Richard Lockshin and Zahra Zaker) of the Cell Death Society and presently serves on the board of Directors of tie International Cell Death Society. Dr. Birge serves as a scientific consultant on numerous federal and private grant study sections that include the National Institutes of Health, National Science Foundation, and the Department of Defence Congressionally directed Breast and Prostate Cancer funding programs.